Corona Remedies IPO Details

Incorporated in August 2004, Corona Remedies Limited is a pharmaceutical company developing, manufacturing, and marketing products in women’s healthcare, cardiology, pain management, urology, and other therapeutic areas.

As of June 30, 2025, the company’s diverse portfolio includes 71 brands across therapeutic areas like women’s healthcare, cardio-diabeto, pain management, urology, and multispecialty pharmaceuticals (including vitamins/minerals/nutrition, gastrointestinal, and respiratory).

The company has a pan-India marketing and distribution network with 2,671 medical representatives in 22 states, enabling effective engagement with healthcare professionals and hospitals, consolidating its presence in the IPM and ensuring deep penetration in therapeutic areas.

The company has two manufacturing facilities, located in the states of Gujarat with an aggregate installed capacity for formulations of 1,285.44 million units per annum.

Competitive Strength:

  • Second fastest growing company in the top 30 Indian pharmaceutical companies by domestic sales from MAT June 2022 to MAT June 2025, well-positioned to seize opportunities in the Indian market.
  • Demonstrated capabilities of building a diversified portfolio, including “engine” brands, in our targeted therapy areas.
  • Pan-India sales network and marketing strategy focused on the “middle of the pyramid” target market.
  • Quality and current Good Manufacturing Practices-focused manufacturing facilities, with strong research and development capabilities driving a portfolio of differentiated pharmaceutical products.
  • Qualified, experienced and entrepreneurial management team supported by marquee investors.

Corona Remedies Ltd. Financial Information (Restated Consolidated)

Corona Remedies Ltd.’s revenue increased by 18% and profit after tax (PAT) rose by 65% between the financial year ending with March 31, 2025 and March 31, 2024.

Period Ended30 Jun 202531 Mar 202531 Mar 202431 Mar 2023
Assets1,012.38929.86830.58595.02
Total Income348.561,202.351,020.93891.10
Profit After Tax46.20149.4390.5084.93
EBITDA71.80245.91161.19135.03
NET Worth607.02606.34480.41408.52
Reserves and Surplus545.86545.18419.25347.36
Total Borrowing106.6562.70134.142.33
Amount in ₹ Crore

Key Performance Indicator (KPI)

KPI  as of Mon, Mar 31, 2025.

KPIValues
ROE27.50%
ROCE41.32%
Debt/Equity0.10
RoNW24.65%
PAT Margin12.49%
EBITDA Margin20.55%
Price to Book Value10.71
 
 Pre IPOPost IPO
EPS Rs24.4330.21
P/E (x)43.4735.15

Note:

  • The value will be calculated using Equity Dilution = Share Holding Pre Issue – Share Holding Post Issue
  • The Pre IPO EPS is calculated based on Pre issue shareholding as on date of RHP and the latest FY earnings as of March 31, 2025 that is available in RHP.
  • The Post Issue EPS is calculated based on the Post issue shareholding and annualized FY earnings of June 30, 2025 that is available in RHP.

 

Corona Remedies IPO Details

IPO Date Mon, Dec 8, 2025 to Wed, Dec 10, 2025
Listing Date [.]
Face Value ₹10 per share
Issue Price Band ₹1008 to ₹1062 per share
Lot Size 14 Shares
Sale Type Offer For Sale
Issue Type Bookbuilding IPO
Listing At BSE, NSE
Employee Discount ₹54.00
Total Issue Size 61,71,101 shares (aggregating up to ₹655.37 Cr)
Share Holding Pre Issue 6,11,60,088 shares
Share Holding Post Issue 6,11,60,088 shares

Corona Remedies IPO Promoter Holding

The company's promoters are Dr. Kirtikumar Laxmidas Mehta, Niravkumar Kirtikumar Mehta and Ankur Kirtikumar Mehta.

Share Holding Pre Issue72.50%
Share Holding Post Issue 

SHARIAH SCREENING for - Corona Remedies IPO Details

Looking to invest ethically or according to Islamic principles? Expert Ethical brokers can help. Whether you need an ethical investment broker, a halal stock broker in India, or a Shariah-compliant broker, there are specialists available. Discover how to align your investments with your values and start your journey towards ethical wealth creation today through Ethical IAP or Ethical PMS.

Visit Prosperia.in to learn more about Ethical Investment Opportunities and start your journey towards ethical wealth creation today.

BUSINESS SCREEN

FINANCIAL RATIOS

As per our analysis and Based on the information we have, this is the output.
Allah knows best.
If you find this result mistaken or questionable, let us know via email at info (@) halalstock.in

Spread the Knowledge - Share the Latest IPO Updates and Shariah Compliant IPO's.

Latest Current & Upcoming IPOs in BSE & NSE - Including Shariah Compliant.

The IPO dashboard offers insights on the Latest Current & Upcoming IPOs in BSE & NSE. It also evaluates IPOs for Shariah compliance, ensuring alignment with Islamic principles for ethical investment choices.

IPO

Srinibas Pradhan Constructions IPO Detail

Last Updated on March 5, 2026 Srinibas Pradhan Constructions Ltd IPO Incorporated in 2020, Srinibas Pradhan Constructions Limited (SPCL) operates in the infrastructure and utilities sector, specializing in the execution

Read More »
IPO

Elfin Agro India IPO Detail

Last Updated on March 5, 2026 Elfin Agro India Ltd. IPO Elfin Agro India Limited is primarily engaged in the business of manufacturing of Chakki Atta (High fibre whole wheat

Read More »
IPO

SEDEMAC Mechatronics IPO Detail

Last Updated on March 5, 2026 SEDEMAC Mechatronics Ltd. IPO Incorporated in 2007, SEDEMAC Mechatronics Ltd is a Pune-based technology company specializing in control electronics. It designs and manufactures powertrain

Read More »

Dear Halal Stock Users,

If you believe our website is a valuable resource,
we invite you to support us.
Your contribution ensures free access for all
and fuels future development.

You can contribute as little as
100, 200, 500 & so…
every bit counts.

Thank you for your support!